Abstract:Irene Gonzalez, 1 Rocio Polvillo, 1, 2 Maximiliano Ruiz-Galdon, 1 Armando Reyes-Engel, 1 Jose Luis Royo 1 1 Department of Surgery, Biochemistry and Immunology School of Medicine, University of Malaga, Malaga, Spain; 2 Centro Andaluz de Biología del Desarrollo, Seville, 41013, Spain Correspondence: Armando Reyes-Engel; Jose Luis Royo Tel +34 952131531 ; +34 952136655 Email ; Purpose: Tryptophan is the only precursor of serotonin, the hormone which helps regulate key human functions such as appetite, memory, mood, and sexual behavior. Connections have been identified between serotonin system dysfunction and the molecular etiology and treatment of mood disorders in a wide range of studies. Proposals have been put forward to co-administer tryptophan supplementation together with serotonin reuptake inhibitors in major depression patients, and also to exploit the sub-therapeutic depressive status in healthy populations. The reported responses, however, have been very dissimilar and this uneven effect may largely be explained by interindividual genetic differences. Materials and Methods: We studied mood change in 138 healthy subjects using both Goldberg's General Health Questionnaire and the Profile of Mood States Questionnaire to determine the effects of a daily supplementation of 1g of tryptophan or placebo. Buccal DNA samples were provided and TPH1 (rs1800532), MAOA (rs3788862 and rs979605), MAOB (rs3027452), and COMT (rs6269 and rs4680) variants were genotyped. Results: MAOB rs3027452 was equally associated with tryptophan supplementation efficacy in the depression subscales of both questionnaires (ΔT-Score.D; ΔT-Score.TMD and ΔPOMS.D p-values < 0.01). Conclusion: Here we provide evidence that tryptophan supplementation has an uneven effect on mood improvement in the general population. Keywords: tryptophan, serotonin, 5-HT, mood, pharmacogenetics, monoamine oxidase Tryptophan (Trp) is an essential amino acid that has to be ingested through protein-rich foods. Plasma Trp levels are the result of both intake and plasma clearance rates. 1 , 2 Trp is the only precursor of serotonin (5-hydroxytryptamine or 5-HT), which is produced both peripherally and centrally. In the central nervous system, 5-HT regulates key functions such as appetite, memory, mood, and sexual activity. 3 The implication of 5-HT in the pathophysiology and treatment of mood disorders has been studied extensively. Mood disturbance is one of the main symptoms of depression, an affective disorder which is the leading cause of disability worldwide. 4 The main therapeutic agents used to treat depression are antidepressants like 5-HT reuptake inhibitors, which can be prescribed alone or in combination with serotonin/noradrenaline reuptake inhibitors. 5 Selective serotonin reuptake inhibitors (SSRIs) act by inhibiting the reuptake of 5-HT into presynaptic cells and thus increasing its extracellular concentration. This increases the amount of 5-HT in the synaptic cleft, binding it to the postsynaptic receptors. SSRIs display different degrees of selectivity for other monoamines such as dopamine and norepinephrine transporters. 6 The benefits of increased monoamine levels were discovered in the 1950s, when monoamine oxidase (MAO) inhibitors and tricyclic antidepressants were found to be efficient in treating major depression patients. This led to the hypothesis that depression was caused by a deficiency in monoamine neurotransmitters. 7 However, antidepressants are only partially effective in the treatment of moderate to severe depression in adults, suggesting that potential pharmacogenetic effects may condition treatment efficiency. 7–11 The benefits of Trp for mood were first reported in the late fifties by Lauer et al 1958 12 . Some early studies conducted with depressed patients found that a daily supplementation of 3.5–18 g of Trp enhanced the therapeutic benefits of MAO inhibitors and tricyclic antidepressants. 13–15 However, although effective in mild to moderately depressed patients, Trp supplementation has been shown to have little or no effect in severely depressed patients. 16 The effects of Trp supplementation on mood in healthy volunteers have also been very varied. Markus et al investigated the effects of different sources -Abstract Truncated-

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation

Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion

Tryptophan supplementation and serotonin function: genetic variations in behavioural effects

No Association Between Tryptophan Hydroxylase-2 Gene G1463A Polymorphism and Unipolar Depression in a Southern Chinese Han Population (translated Version)

Tryptophan-enriched diet or 5-hydroxytryptophan supplementation given in a randomized controlled trial impacts social cognition on a neural and behavioral level

Tryptophan Metabolism in Health and Disease

SLC6A4 polymorphisms modulate the efficacy of a tryptophan-enriched diet on age-related depression and social cognition

The Effects of Tryptophan Depletion on Cognitive and Affective Processing in Healthy Volunteers

The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study

Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response

Beneficial Effect of Increased Tryptophan Intake on Its Metabolism and Mental State of the Elderly

A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men

Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review

Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder

Mood, Prolactin and Cortisol Responses Following Intravenous L-tryptophan Challenge: Evidence for Serotonergic Vulnerability in First-Degree Relatives of Bipolar Patients.

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders

Association of tryptophan pathway metabolites with mortality and effectiveness of nutritional support among patients at nutritional risk: secondary analysis of a randomized clinical trial

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.

Additive Effect of Tryptophan Hydroxylase 1 and Monoamine Oxidase A Gene on Negative Emotional Management in Depressive Frontal Subregions

Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female Chinese population

The Relationship of Tryptophan Hydroxylase-2 Methylation to Early-Life Stress and Its Impact on Short-Term Antidepressant Treatment Response.